(c) 2024 PillSync.com

Gabapentin gabapentin 300 MG Oral Capsule

INDICATIONS AND USAGE Postherpetic Neuralgia Gabapentin capsules are indicated for the Management of postherpetic neuralgia in adults. Epilepsy Gabapentin capsules are indicated as adjunctive therapy in the treatment of partial seizures with and without secondary generalization in patients over 12 years of age with epilepsy. Gabapentin capsules are also indicated as adjunctive therapy in the treatment of partial seizures in pediatric patients age 3 to 12 years.

MedVantx Inc.


7 years ago CAPSULE ORANGE 93 39 Gabapentin  gabapentin 300 MG Oral Capsule

CAPSULE ORANGE 93 39

7 years ago CAPSULE ORANGE 93 39 Gabapentin  gabapentin 300 MG Oral Capsule

93 39 CAPSULE ORANGE

HOW SUPPLIED Gabapentin capsules USP are available as follows: 300 mg - No. 0 hard gelatin capsules with an orange cap and body, filled with a white to off-white powder with small agglomerates, available in unit-dose boxes of 100 (10 x 10) and bottles of 1000. Both the capsule body and cap are imprinted with “93” and “39”. Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required). All brand names listed are the registered trademarks of their respective owners and are not trademarks of Teva Pharmaceuticals USA. Manufactured In Israel By: TEVA PHARMACEUTICAL IND. LTD. Jerusalem, 91010, Israel Manufactured For: TEVA PHARMACEUTICALS USA Sellersville, PA 18960 Rev. T 8/2011


More pills like CAPSULE 93 39












DISCLAIMER:

"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."

"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."

"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."

PillSync may earn a commission via links on our site